Source: Annual Congress 2008 - Basic science in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Liu, G. Lauer, A. Hatzelmann, C. Hesslinger (Konstanz, Germany). The role of inducible NO synthase (iNOS) in a cell model of steroid resistance in chronic obstructive pulmonary disease. Eur Respir J 2008; 32: Suppl. 52, 3578

Member's Comments

No comment yet.

Related content which might interest you: Increased expression of inducible nitric oxide synthase (iNOS) in peripheral lung of severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Polymorphism of the cyclo-oxygenase-2 gene protects against the development of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Source: Eur Respir J 2003; 21: 394-400 Year: 2003 Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 The effect of mtTFA methylation in the pathogenesis of pulmonary vascular endothelial cell apoptosis of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function Source: Eur Respir J 2001; 17: 934-938 Year: 2001 Attenuated expression and activity of dimethylarginine dimethylaminohydrolase may play a key role in monocrotaline-induced pulmonary hypertension by accumulation of endogenous NOS inhibitors in rats Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Pulmonary hypertension: future therapies Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=84 Year: 2004 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Expression of inducible nitiric oxide synthase (iNOS) in airway epithelial cells is reduced in young children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Value of induced sputum nitric oxide and 3-Nitrotyrosine(3NT) levels in differentiating obstructive and inflammatory diseases of lung Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003